Home › Cases › After Thrombolysis
Angioedema
After Thrombolysis
6 questions
Question 1 · Forty minutes into the stroke pathway
Correct answer: Orolingual angioedema, a recognised association with thrombolysis
Why
Orolingual angioedema is a recognised complication of alteplase, and the risk is higher in patients taking ACE inhibitors — she is on lisinopril.
It is often asymmetrical, sometimes contralateral to the infarct, which is a detail that makes people doubt themselves.
It can develop fast, and an airway that closes during a stroke thrombolysis is a rescue nobody wants to be starting late.
Key point
Alteplase plus an ACE inhibitor is a recognised angioedema combination. It can be asymmetrical.
Question 2 · The first calls
Correct answer: Stop the alteplase infusion and call anaesthetics and the stroke team immediately
Why
Stop the infusion and get the airway people moving. The airway is the immediate threat, and the stroke team need to be part of the decision about the remaining dose.
Sit her up, unless her stroke care dictates otherwise, and prepare for a difficult airway — tongue swelling makes intubation hard and a surgical airway harder.
Drugs come second here, and antihistamine alone is not a plan for a swelling tongue.
Key point
Stop the infusion, call anaesthetics and the stroke team. The airway outranks the remaining dose.
Question 3 · Which mechanism
Correct answer: Bradykinin is much likelier, so adrenaline, steroids and antihistamines are unlikely to work — and the airway is the management
Why
No urticaria, no itch — bradykinin is much likelier. Alteplase and ACE inhibitors both raise bradykinin, which is why they combine to produce this.
So the standard drugs are unlikely to work. Giving them remains right when anaphylaxis cannot confidently be excluded and there is ABC compromise; in a clearly bradykinin-mediated presentation they are not routine.
Either way the plan cannot be to give them and wait. The airway is the management, and non-response is information rather than a reason to keep repeating doses.
Key point
No urticaria makes bradykinin likelier. Expect non-response, and make the airway the plan.
Question 4 · Escalating
Correct answer: Early definitive airway management with senior anaesthetic and ENT presence and a surgical airway plan
Why
Secure the airway early, while it is still possible. Tongue and laryngeal swelling gets worse before it gets better, and a difficult intubation becomes an impossible one over minutes.
That means senior anaesthetics, ENT, and a surgical airway plan in the room — a front-of-neck approach prepared, not improvised.
Nebulised adrenaline may be used as a temporising measure, but it is not a plan on its own in bradykinin-mediated swelling with stridor.
Key point
Secure it early. In this swelling, waiting converts a difficult airway into an impossible one.
Question 5 · The specific treatments
Correct answer: These are specialist considerations; your job is the airway, the calls and stopping the drug
Why
Know that they exist, and let the people who use them decide. Bradykinin-targeted agents have been used in severe ACE-inhibitor and thrombolysis-associated angioedema, but availability, evidence and local policy vary.
The F1 contribution is the part that is reliably decisive: stop the infusion, sit her up, call anaesthetics and ENT, stop the ACE inhibitor, and stay with her.
Hereditary angioedema is where these agents are unambiguous — and there, the patient often carries their own.
Key point
Airway, calls, stop the drugs. The specific agents are a specialist call.
Question 6 · Afterwards
Correct answer: Lisinopril stopped permanently and recorded as an allergy, with the thrombolysis reaction recorded too
Why
Both go on the record. The ACE inhibitor stops permanently — it can cause angioedema after years and did so here under provocation. The thrombolysis reaction must be documented too, because it is relevant if she ever needs it again.
ARBs carry a lower but real risk, so any switch is a deliberate decision rather than a default substitution.
A discharge-summary sentence is not enough. It goes on the allergy record, where a prescribing system will act on it.
Key point
Both drugs on the allergy record. ARBs are lower risk, not no risk.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.